Post-Marketing Surveillance Orgalutran (Ganirelix)®
Post-Marketing Surveillance Orgalutran (Ganirelix)®
The purpose of this post-marketing surveillance is to identify problems and questions regarding the safety and efficacy of Orgalutran (Ganirelix)® when used for the prevention of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation (COH) for assisted reproduction techniques (ART).
Inclusion Criteria:
Exclusion Criteria: